Long-term outcome of thoracoscopic lobectomy for non-small cell lung cancer: series of consecutive 1131 patients in single center

隋锡朝,杨帆,李运,陈克终,李晓,赵辉,周足力,周健,杨锋

DOI: https://doi.org/10.3760/cma.j.issn.1001-4497.2015.08.006

2015-01-01

Abstract:Objective To summarize the experience of completely thoracoscopic lobectomy for non-small-cell lung cancer(NSCLC) in a single center and to evaluate the long-term outcome.Methods The data of 1 131 NSCLC patients who received completely thoracoscopic lobectomy in Peking University People's Hospital between September 2006 and April 2011 were retrospectively reviewed.594 males and 537 females with an average age of 61.5 years old were included.Completely thoracoscopic lobectomy and systematic lymph node dissection were performed,including lobectomy in 1 075 cases,bilobectomy in 23 and sleeve lobectomy in 20,pneumectomy in 12,and bilateral lobectomy in 1.Results 1 045 of all 1 131 cases finished completely thoracoscopic anatomic lobectomy,the other 87 cases converted to thoracotomy with a conversion rate of 7.7％.The median surgical duration was 180 min,and median intraoperative blood loss was 100 ml.The average chest tube duration was 6.4 days,and average postoperative hospital stay was 8.8 days.Postoperative complications were reported in 154 cases (13.6％),and death were reported in 7 patients during perioperative period with a perioperative mortality of 0.6％.Pathology:909 (80.4％) adenocarcinomas including 55 (4.9％) adenocarcinomas in situ,181 (16.0％) squamous carcinomas,17 (1.5％) adenosquamous carcinomas,14(1.2％) large cell carcinomas,10(0.9％) NOS.The 1-year,3-year and 5-year DFS survival rates were 91.5％,77.5％ and 76.4％ respectively.The 1-year,3-year and 5-year overall survival rates were 96.0％,85.4％ and 76.4％ respectively.Conclusion Completely thoracoscopic lobectomy was a safe and effective mini-invasive procedure for resectable NSCLC.Its long-term outcome was remarkable.